The Boston Globe to Host Rare Disease Summit
Second Annual Rare Disease Summit to Bring Together Advocates, Experts, and Industry Leaders, February 24; register now at globe.com/rarediseaseBOSTON, Feb....
Read moreDetails
Uncategorized
MetaVia Builds Comprehensive Global Patent Protection for DA-1726, Securing Exclusive Rights to Novel Obesity and Metabolic Therapy Through 2041
Intellectual Property Portfolio Includes 39 Granted and Pending Patents in the U.S. and Internationally, Providing Protection Into 2041, Unless Extended...
Read moreDetailsLunai Bioworks (NASDAQ: LNAI) Highlights Drug Discovery and Biodefense AI Platform on CNBC
SACRAMENTO, Calif., Feb. 13, 2026 /PRNewswire/ -- Lunai Bioworks (NASDAQ: LNAI), an AI-powered biotech and biodefense company, was featured on...
Read moreDetailsPerrigo to Release Fourth Quarter and Fiscal Year 2025 Financial Results on February 26, 2026
DUBLIN, Feb. 13, 2026 /PRNewswire/ -- Perrigo Company plc (NYSE: PRGO), a leading provider of consumer health products, today announced...
Read moreDetailsLas Vegas Sands Board of Directors Appoints Patrick Dumont as Chairman and Chief Executive Officer
Mr. Dumont has served as the company's president and chief operating officer since 2021LAS VEGAS, Feb. 13, 2026 /PRNewswire/ --...
Read moreDetailsEvergood Sausage Company Celebrates 100 Year Anniversary of Craftsmanship, Family Leadership, and Hardwood-Smoked Tradition
Three generations of family ownership and a century of maintaining the founding mission and values looks ahead to its next...
Read moreDetailsCitius Oncology, Inc. Announces First Reported Revenue Following Successful Launch of LYMPHIR™
Company reports $3.9 million in revenue generated from initial sales in December 2025 and provides first fiscal quarter 2026 financial...
Read moreDetails
Boston Scientific to participate in TD Cowen’s 46th Annual Health Care Conference
MARLBOROUGH, Mass., Feb. 13, 2026 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) will participate in TD Cowen's 46th Annual Health...
Read moreDetailsCitius Pharmaceuticals, Inc. Announces First Reported Revenue Following Successful Launch of LYMPHIR™
Company reports $3.9 million in revenue generated from initial sales in December 2025 and provides first fiscal quarter 2026 financial...
Read moreDetailsMedtronic receives FDA clearance for Stealth AXiS™ surgical system, first integrated planning, navigation and robotics platform for spine surgery
GALWAY, Ireland, Feb. 13, 2026 /PRNewswire/ -- Medtronic (NYSE: MDT), a global leader in healthcare technology, today announced U.S. Food and...
Read moreDetails